Sandoz chief executive Richard Saynor has taken a further leadership position at the top of the off-patent industry after being named as the chair of the International Generic and Biosimilar Medicines Association’s CEO advisory committee.
At the same time, Lupin CEO Vinita Gupta has been named as vice-chair of the committee
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?